RYAN FRAZINE: Open Payments
NPI 1548339070 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,909 in 120 payments from 22 companies in 2025. Trend: 2023 $1,359 · 2024 $1,956 · 2025 $1,909
Food & beverage: $1,909
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $345 |
| ABBVIE INC. | 28 | $320 |
| AstraZeneca Pharmaceuticals LP | 6 | $181 |
| Lilly USA, LLC | 9 | $124 |
| Eisai Inc. | 4 | $114 |
| PFIZER INC. | 6 | $102 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Axsome Therapeutics, Inc. | 5 | $95 |
| Phathom Pharmaceuticals, Inc. | 9 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86 |
Products named: Wegovy, FARXIGA, UBRELVY, Leqembi, Ozempic, MOUNJARO, JARDIANCE, LEQVIO.
Industry payments across KY — which companies pay providers there.
